Professional
Added to YB: 2024-08-22
Pitch date: 2024-08-21
CUTR [neutral]
Cutera, Inc.
-99.08%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products.
Market Cap
$201.9K
Pitch Price
$0.90
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.92
P/E
-0.00
EV/Sales
2.42
Sector
Health Care Equipment and Supplies
Category
turnaround
Pernas Research Passes On: Cutera, Inc.
CUTR pass: $17.6M mkt cap, $.88/share. Heavily indebted aesthetic product co. AviClear FDA-approved laser acne treatment. Promising tech but mismanagement, ops issues & macro challenges. Possible debt exchange w/ '26 converts (30c/$). Reorg likely, highly dilutive to equity. Monitoring convert opportunity.
Read full article (1 min)